Gefitinib

Gefitinib is a pioneer that rewrote the rules of oncology. It was the world's first "smart pill" for lung cancer, proving that you don't need to bombard the whole body with chemotherapy to stop a tumor. Acting like a sniper, Gefitinib targets cancer cells with a specific EGFR gene mutation and jams the enzyme that fuels their growth. The tumor engine simply shuts down. It offers a lifeline for non-small cell lung cancer (NSCLC) patients, prioritizing both survival and quality of life.